Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wilate in Previously Treated Patients With Severe Hemophilia A
NCT02954575Phase 3Completed
- Sponsor
- Octapharma
- Start
- Dec 2016
- Primary completion
- Mar 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 5
01
Overview
A Phase 3 trial of von Willebrand factor concentrate in hemophilia A, sponsored by Octapharma. Started Dec 2016; status: completed.
02
Drugs
von Willebrand factor concentrate
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT02954575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02954575.